Jan 25, 2023
In this week’s View, Dr. Eagle discusses recurrent venous thromboembolism and bleeding with extended anticoagulation and the VTE-PREDICT risk score, then looks at infective endocarditis after transcatheter aortic valve replacement (TAVR). Finally, Dr. Eagle explores aspirin and low-molecular-weight heparin...
Jan 18, 2023
In this week’s View, Dr. Eagle discusses the treatment of radiation-induced aortic stenosis, then looks at PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection. Finally, Dr. Eagle explores myocardial injury on CMR in patients with COVID-19 and suspected cardiac involvement.
Jan 11, 2023
In this week’s View, Dr. Eagle discuses heart failure drug treatment - inertia, titration and discontinuation as analyzed in EVOLUTION HF, a multinational observational study, then looks at Non-Obstructive Coronary Arteries (INOCA), and insights gained from the ISCHEMIA Trial. Finally, Dr. Eagle explores findings...
Dec 21, 2022
Top Clinical Trials
It was another great year for trial coverage on ACC.org! There were almost 140,000 unique views of the top 10 trials and top 10 trial updates for the year. Treatment of heart failure and of hypertrophic cardiomyopathy were hot topics. In addition to covering new trials, we updated prior trials with...
Dec 20, 2022
In 2022 with much of the care landscape returning to more normalcy after the COVID-19 pandemic eased, we saw the most visited journal scan content on ACC.org once again focused on common areas of cardiovascular practice and areas with advances in therapy. ACC.org is a home for condensed, digestible content particularly...